Allogeneic hematopoietic cell transplantation (alloHCT) for patients over 65 years old is not associated with worse symptoms/function than younger patients - a Center for International Blood and Marrow Transplant Research (CIBMTR) study
Conferences
Shaw, B; Brazauskas, R; Burns, LJ; Mattila, D; Musseter, A; Chen, M; Vasu, S; Pidala, J; Muffly, L; Uberti, J; Tamari, R; Leckrone, E ...
Published in: QUALITY OF LIFE RESEARCH
October 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
QUALITY OF LIFE RESEARCH
EISSN
1573-2649
ISSN
0962-9343
Publication Date
October 2020
Volume
29
Issue
SUPPL 1
Start / End Page
S29 / S29
Related Subject Headings
- Health Policy & Services
- 44 Human society
- 42 Health sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Shaw, B., Brazauskas, R., Burns, L. J., Mattila, D., Musseter, A., Chen, M., … Flynn, K. E. (2020). Allogeneic hematopoietic cell transplantation (alloHCT) for patients over 65 years old is not associated with worse symptoms/function than younger patients - a Center for International Blood and Marrow Transplant Research (CIBMTR) study. In QUALITY OF LIFE RESEARCH (Vol. 29, pp. S29–S29).
Shaw, Bronwen, Ruta Brazauskas, Linda J. Burns, Deborah Mattila, Alisha Musseter, Min Chen, Sumithira Vasu, et al. “Allogeneic hematopoietic cell transplantation (alloHCT) for patients over 65 years old is not associated with worse symptoms/function than younger patients - a Center for International Blood and Marrow Transplant Research (CIBMTR) study.” In QUALITY OF LIFE RESEARCH, 29:S29–S29, 2020.
Shaw B, Brazauskas R, Burns LJ, Mattila D, Musseter A, Chen M, et al. Allogeneic hematopoietic cell transplantation (alloHCT) for patients over 65 years old is not associated with worse symptoms/function than younger patients - a Center for International Blood and Marrow Transplant Research (CIBMTR) study. In: QUALITY OF LIFE RESEARCH. 2020. p. S29–S29.
Shaw, Bronwen, et al. “Allogeneic hematopoietic cell transplantation (alloHCT) for patients over 65 years old is not associated with worse symptoms/function than younger patients - a Center for International Blood and Marrow Transplant Research (CIBMTR) study.” QUALITY OF LIFE RESEARCH, vol. 29, no. SUPPL 1, 2020, pp. S29–S29.
Shaw B, Brazauskas R, Burns LJ, Mattila D, Musseter A, Chen M, Vasu S, Pidala J, Muffly L, Uberti J, Tamari R, Leckrone E, Myers J, Mau L-W, Rizzo JD, Saber W, Horowitz MM, Lee SJ, Flynn KE. Allogeneic hematopoietic cell transplantation (alloHCT) for patients over 65 years old is not associated with worse symptoms/function than younger patients - a Center for International Blood and Marrow Transplant Research (CIBMTR) study. QUALITY OF LIFE RESEARCH. 2020. p. S29–S29.
Published In
QUALITY OF LIFE RESEARCH
EISSN
1573-2649
ISSN
0962-9343
Publication Date
October 2020
Volume
29
Issue
SUPPL 1
Start / End Page
S29 / S29
Related Subject Headings
- Health Policy & Services
- 44 Human society
- 42 Health sciences